News Teva files orphan blockbuster hope in tardive dyskinesia SD-809 will be vital for Teva if approved.
Views & Analysis Orphan drugs will fuel pharma's future - and a pricing pushb... Evaluate predicts sales could approach $8bn if approved.
News Teva's CEO Vigodman steps down Firm searches for new leader, chairman takes over on interim basis.
News Novartis faces bribery probe in Greece Prosecutors raid Athens offices, according to press reports.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
